Definitions matter: Heterogeneity of COVID-19 disease severity criteria and incomplete reporting compromise meta-analysis.
Therapeutic efficacy in COVID-19 is dependent upon disease severity (treatment effect heterogeneity). Unfortunately, definitions of severity vary widely. This compromises the meta-analysis of randomised controlled trials (RCTs) and the therapeutic guidelines derived from them. The World Health Organ...
Saved in:
Main Authors: | Philippe J Guérin (Author), Alistair R D McLean (Author), Sumayyah Rashan (Author), AbdulAzeez Lawal (Author), James A Watson (Author), Nathalie Strub-Wourgaft (Author), Nicholas J White (Author) |
---|---|
Format: | Book |
Published: |
Public Library of Science (PLoS),
2022-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Definitions matter: Heterogeneity of COVID-19 disease severity criteria and incomplete reporting compromise meta-analysis
by: Philippe J. Guérin, et al.
Published: (2022) -
Correction: Definitions matter: heterogeneity of COVID-19 disease severity criteria and incomplete reporting compromise meta-analysis.
by: PLOS Global Public Health Staff
Published: (2023) -
The Chagas disease study landscape: A systematic review of clinical and observational antiparasitic treatment studies to assess the potential for establishing an individual participant-level data platform.
by: Brittany J Maguire, et al.
Published: (2021) -
The earliest case definition of suspected case of COVID-19 by WHO: Whether it was incomplete?
by: Sunil Kumar Garg, et al.
Published: (2021) -
Clinical definition and diagnostic criteria for sarcopenia
by: Jun Udaka, et al.
Published: (2014)